A novel patient-derived xenograft model for claudin-low triple-negative breast cancer.
Saved in:
| Title: | A novel patient-derived xenograft model for claudin-low triple-negative breast cancer. |
|---|---|
| Authors: | Matossian MD; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Burks HE; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Bowles AC; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Elliott S; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Hoang VT; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Sabol RA; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA., Pashos NC; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA.; Department of Biomedical Engineering, Tulane University, New Orleans, LA, USA., O'Donnell B; Department of Biomedical Engineering, Tulane University, New Orleans, LA, USA., Miller KS; Department of Biomedical Engineering, Tulane University, New Orleans, LA, USA., Wahba BM; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA., Bunnell BA; Tulane Center for Stem Cell Research and Regenerative Medicine, New Orleans, LA, USA.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA., Moroz K; Department of Pathology, Tulane University School of Medicine, New Orleans, LA, USA.; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA., Zea AH; Louisiana Cancer Research Center, Biospecimen Core, New Orleans, LA, USA.; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Jones SD; Department of Surgery, Tulane University School of Medicine, New Orleans, LA, USA.; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA., Ochoa AC; Louisiana State University Health Sciences Center, Biochemistry and Molecular Biology, New Orleans, LA, USA., Al-Khami AA; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Hossain F; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Riker AI; Department of Surgery, Louisiana State University Health Sciences Center, New Orleans, LA, USA., Rhodes LV; Department of Biology, Florida Gulf Coast University, Fort Myers, FL, USA., Martin EC; Department of Biological and Agricultural Engineering, Louisiana State University, Baton Rouge, LA, USA., Miele L; Louisiana State University Health Sciences Center, New Orleans, LA, USA., Burow ME; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA.; Department of Pharmacology, Tulane University School of Medicine, New Orleans, LA, USA., Collins-Burow BM; Department of Medicine, Section of Hematology & Medical Oncology, Tulane University School of Medicine, New Orleans, LA, USA. bcollin1@tulane.edu.; Tulane Cancer Center, Tulane University School of Medicine, New Orleans, LA, USA. bcollin1@tulane.edu. |
| Source: | Breast cancer research and treatment [Breast Cancer Res Treat] 2018 Jun; Vol. 169 (2), pp. 381-390. Date of Electronic Publication: 2018 Feb 01. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Kluwer Academic Country of Publication: Netherlands NLM ID: 8111104 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1573-7217 (Electronic) Linking ISSN: 01676806 NLM ISO Abbreviation: Breast Cancer Res Treat Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1573-7217 |
|---|---|
| DOI: | 10.1007/s10549-018-4685-2 |
